vs

Side-by-side financial comparison of CLOVER HEALTH INVESTMENTS, CORP. (CLOV) and Unity Software Inc. (U). Click either name above to swap in a different company.

Unity Software Inc. is the larger business by last-quarter revenue ($503.1M vs $487.7M, roughly 1.0× CLOVER HEALTH INVESTMENTS, CORP.). CLOVER HEALTH INVESTMENTS, CORP. runs the higher net margin — -10.1% vs -17.9%, a 7.8% gap on every dollar of revenue. On growth, CLOVER HEALTH INVESTMENTS, CORP. posted the faster year-over-year revenue change (44.7% vs 10.1%). Unity Software Inc. produced more free cash flow last quarter ($118.7M vs $-69.0M). Over the past eight quarters, CLOVER HEALTH INVESTMENTS, CORP.'s revenue compounded faster (18.6% CAGR vs 4.5%).

Clover Health Investments, Corp. is an American health care company founded in 2014. The company provides Medicare Advantage (MA) insurance plans and operates as a direct contracting entity with the U.S. government. The company manages care for Medicare beneficiaries in 11 states and started trading publicly on January 8, 2021.

Unity Software Inc. is an American video game software development company based in San Francisco. It was founded in Denmark in 2004 as Over the Edge Entertainment and changed its name in 2007. Unity Technologies is best known for the development of Unity, a licensed game engine used to create video games and other applications.

CLOV vs U — Head-to-Head

Bigger by revenue
U
U
1.0× larger
U
$503.1M
$487.7M
CLOV
Growing faster (revenue YoY)
CLOV
CLOV
+34.7% gap
CLOV
44.7%
10.1%
U
Higher net margin
CLOV
CLOV
7.8% more per $
CLOV
-10.1%
-17.9%
U
More free cash flow
U
U
$187.7M more FCF
U
$118.7M
$-69.0M
CLOV
Faster 2-yr revenue CAGR
CLOV
CLOV
Annualised
CLOV
18.6%
4.5%
U

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
CLOV
CLOV
U
U
Revenue
$487.7M
$503.1M
Net Profit
$-49.3M
$-90.0M
Gross Margin
74.3%
Operating Margin
-10.1%
-21.2%
Net Margin
-10.1%
-17.9%
Revenue YoY
44.7%
10.1%
Net Profit YoY
-123.2%
26.7%
EPS (diluted)
$-0.21

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CLOV
CLOV
U
U
Q4 25
$487.7M
$503.1M
Q3 25
$496.6M
$470.6M
Q2 25
$477.6M
$440.9M
Q1 25
$462.3M
$435.0M
Q4 24
$337.0M
$457.1M
Q3 24
$331.0M
$446.5M
Q2 24
$356.3M
$449.3M
Q1 24
$346.9M
$460.4M
Net Profit
CLOV
CLOV
U
U
Q4 25
$-49.3M
$-90.0M
Q3 25
$-24.4M
$-126.4M
Q2 25
$-10.6M
$-108.8M
Q1 25
$-1.3M
$-77.6M
Q4 24
$-22.1M
$-122.7M
Q3 24
$-9.2M
$-124.7M
Q2 24
$7.4M
$-125.6M
Q1 24
$-19.2M
$-291.1M
Gross Margin
CLOV
CLOV
U
U
Q4 25
74.3%
Q3 25
74.4%
Q2 25
74.1%
Q1 25
73.8%
Q4 24
74.7%
Q3 24
24.5%
74.9%
Q2 24
30.3%
75.8%
Q1 24
23.6%
68.6%
Operating Margin
CLOV
CLOV
U
U
Q4 25
-10.1%
-21.2%
Q3 25
-4.9%
-26.7%
Q2 25
-2.2%
-26.9%
Q1 25
-0.3%
-29.4%
Q4 24
-6.4%
-27.1%
Q3 24
-2.7%
-28.5%
Q2 24
2.0%
-28.8%
Q1 24
-6.5%
-81.4%
Net Margin
CLOV
CLOV
U
U
Q4 25
-10.1%
-17.9%
Q3 25
-4.9%
-26.9%
Q2 25
-2.2%
-24.7%
Q1 25
-0.3%
-17.8%
Q4 24
-6.6%
-26.8%
Q3 24
-2.8%
-27.9%
Q2 24
2.1%
-28.0%
Q1 24
-5.5%
-63.2%
EPS (diluted)
CLOV
CLOV
U
U
Q4 25
$-0.21
Q3 25
$-0.30
Q2 25
$-0.26
Q1 25
$-0.19
Q4 24
$-0.30
Q3 24
$-0.31
Q2 24
$-0.32
Q1 24
$-0.75

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CLOV
CLOV
U
U
Cash + ST InvestmentsLiquidity on hand
$78.3M
$2.1B
Total DebtLower is stronger
Stockholders' EquityBook value
$308.7M
$3.2B
Total Assets
$541.0M
$6.8B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CLOV
CLOV
U
U
Q4 25
$78.3M
$2.1B
Q3 25
$1.9B
Q2 25
$1.7B
Q1 25
$1.5B
Q4 24
$194.5M
$1.5B
Q3 24
$288.0M
$1.4B
Q2 24
$254.8M
$1.3B
Q1 24
$208.3M
$1.2B
Stockholders' Equity
CLOV
CLOV
U
U
Q4 25
$308.7M
$3.2B
Q3 25
$340.9M
$3.2B
Q2 25
$344.2M
$3.2B
Q1 25
$336.1M
$3.2B
Q4 24
$341.1M
$3.2B
Q3 24
$342.2M
$3.2B
Q2 24
$324.9M
$3.2B
Q1 24
$292.5M
$3.2B
Total Assets
CLOV
CLOV
U
U
Q4 25
$541.0M
$6.8B
Q3 25
$559.7M
$6.8B
Q2 25
$575.0M
$6.7B
Q1 25
$583.7M
$6.6B
Q4 24
$580.7M
$6.7B
Q3 24
$653.0M
$6.7B
Q2 24
$674.2M
$6.7B
Q1 24
$671.8M
$6.8B

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CLOV
CLOV
U
U
Operating Cash FlowLast quarter
$-66.9M
$121.4M
Free Cash FlowOCF − Capex
$-69.0M
$118.7M
FCF MarginFCF / Revenue
-14.1%
23.6%
Capex IntensityCapex / Revenue
0.4%
0.5%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-69.2M
$403.9M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CLOV
CLOV
U
U
Q4 25
$-66.9M
$121.4M
Q3 25
$12.1M
$155.4M
Q2 25
$5.4M
$133.1M
Q1 25
$-16.3M
$13.0M
Q4 24
$34.8M
$112.2M
Q3 24
$50.0M
$122.4M
Q2 24
$44.8M
$88.4M
Q1 24
$25.9M
$-7.4M
Free Cash Flow
CLOV
CLOV
U
U
Q4 25
$-69.0M
$118.7M
Q3 25
$11.4M
$151.3M
Q2 25
$4.8M
$126.7M
Q1 25
$-16.5M
$7.3M
Q4 24
$33.3M
$105.8M
Q3 24
$49.6M
$115.2M
Q2 24
$44.4M
$79.6M
Q1 24
$25.5M
$-14.6M
FCF Margin
CLOV
CLOV
U
U
Q4 25
-14.1%
23.6%
Q3 25
2.3%
32.1%
Q2 25
1.0%
28.7%
Q1 25
-3.6%
1.7%
Q4 24
9.9%
23.1%
Q3 24
15.0%
25.8%
Q2 24
12.5%
17.7%
Q1 24
7.3%
-3.2%
Capex Intensity
CLOV
CLOV
U
U
Q4 25
0.4%
0.5%
Q3 25
0.1%
0.9%
Q2 25
0.1%
1.5%
Q1 25
0.0%
1.3%
Q4 24
0.5%
1.4%
Q3 24
0.1%
1.6%
Q2 24
0.1%
2.0%
Q1 24
0.1%
1.6%
Cash Conversion
CLOV
CLOV
U
U
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
6.04×
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CLOV
CLOV

Segment breakdown not available.

U
U

Grow Solutions$338.2M67%
Create Solutions$164.9M33%

Related Comparisons